O’Melveny advised Superfluid DX on the transaction. Superfluid DX, a San Francisco-based company which specializes in advancing solutions for the diagnosis of Alzheimer’s disease, closed its...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here